• SEC Filings

Aquestive Therapeutics, Inc. (NASDAQ: AQST) Files An 8-K Regulation FD Disclosure
Item 7.01

Regulation FD Disclosure

Aquestive Therapeutics, Inc. is furnishing the investor presentations attached as Exhibit 99.1 and Exhibit 99.2 to this report for use at the BMO Prescriptions for Success Conference on December 12, 2018, and in other meetings with investors and analysts.

The information in this report is being furnished to Item 7.01 and shall not be deemed to be “filed” for purposes of Section 17 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act.

(d) Exhibits.

Aquestive Therapeutics, Inc. Exhibit
EX-99.1 2 ex99_1.htm EXHIBIT 99.1 Exhibit 99.1  Business UpdateDecember 2018     2  Forward Looking Statements  Certain statements in this presentation and associated oral statements made by management may constitute “forward-looking statements.” Words such as “believes”,…
To view the full exhibit click here